Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013 Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …
News
kela-madar

Biotec Services expands presence in Israel

May 20, 2013 Research and Development, Sales and Marketing Biotec

Clinical supplies firm Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli agent. …
Appointment
rawlins_nice

NICE chairman joins biotech Board

May 17, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Intra-Cellular Therapies, NICE, Rawlins

Biotech firm Intra-Cellular Therapies has appointed former NICE chairman Professor Sir Michael Rawlins to its Board of directors. Rawlins was …
Appointment
Elan image

Elan signs $1 billion finance deal with Theravance

May 15, 2013 Research and Development, Sales and Marketing Elan, Theravance, royalty pharma

Elan has struck a novel deal with Theravance which gives it a share of potential future royalties from its respiratory …
News
sumant_hospira__033retoucha

Hospira Reappoints chief scientific officer

May 15, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Hospira

Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …
Appointment
Pfizer image

Pfizer targets Newcastle

May 15, 2013 Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer

Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …
News

Optimer Pharmaceuticals appoints chief operating officer

May 14, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Biopharma firm Optimer Pharmaceuticals has announced the appointment of Eric Sirota as chief operating officer.  “Eric has tremendous experience and …
Appointment
EMA image

EMA ponders biosimilar guideline

May 14, 2013 Research and Development, Sales and Marketing EMA, biosimilars

The European Medicines Agency is thinking about changes to its guidance on similar biological medicines and has published a draft …
News
Lilly image

Lilly takes $30m hit

May 13, 2013 Research and Development, Sales and Marketing enzastaurin, lilly

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …
News

John LaMattina: India’s solution to drug costs

May 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …
Feature

New Board member for Misonix

May 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Misonix

Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.The addition of Vizirgianakis …
Appointment
Takeda image

Takeda to buy Inviragen

May 10, 2013 Research and Development, Sales and Marketing Inviragen, Takeda

Takeda has hit the acquisition trail, putting together a $250 million package to buy private US biopharma firm Inviragen in …
News
stan_musial

Egalet appoints Stan Musial as CFO

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Egalet, musial

Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer.  Bob Radie, president and chief …
Appointment
danai_brooks

Dyadic International hires chief operating officer

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing dyadic

Biotech firm Dyadic International has appointed Danai Brooks to the role of executive VP and chief operating officer.  Starting in …
Appointment
ABPI image

VBP will be ‘unfair’: report

May 8, 2013 Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP

A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026